SCHEMBL3288762

SCHEMBL3288762

CCCN(CCC)c1ccc(C)c(N)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100B P04271 1/20 0.52
TDP1 Q9NUW8 3/20 0.43
ALDH1A1 P00352 3/20 0.43
CASP1 P29466 1/20 0.43
IGLV6-57 P01721 1/20 0.41
CYP3A4 P08684 4/20 0.41
S1PR1 P21453 2/20 0.38
MAPT P10636 1/20 0.37
AR P10275 1/20 0.37
TSHR P16473 3/20 0.36
MAPK1 P28482 2/20 0.36
PSMD14 O00487 1/20 0.36
RECQL P46063 1/20 0.36
GFER P55789 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CRHR1 P34998 1/20 0.35
SKP2 Q13309 1/20 0.34
APAF1 O14727 1/20 0.34
KDM4E B2RXH2 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15172676 0.89 S100B (0.49) S100BTDP1ALDH1A1CASP1CYP3A4
Fluoride SCHEMBL2328935 0.87 S100B (0.47) S100BTDP1ALDH1A1CASP1CYP3A4
SCHEMBL7100535 0.85 S100B (0.72) S100BTDP1ALDH1A1IGLV6-57CYP3A4
SCHEMBL538824 0.84 S100B (0.71) S100BTDP1ALDH1A1CASP1IGLV6-57
SCHEMBL16970730 0.83 S100B (0.46) S100BTDP1ALDH1A1CASP1CYP3A4
Hydrochloric Acid SCHEMBL28014076 0.82 S100B (0.69) S100BTDP1ALDH1A1CASP1IGLV6-57
SCHEMBL24220504 0.82 S100B (0.47) S100BTDP1ALDH1A1IGLV6-57S1PR1
SCHEMBL28245671 0.80 S100B (0.51) S100BTDP1ALDH1A1CASP1IGLV6-57
SCHEMBL6753912 0.80 S100B (0.51) S100BTDP1ALDH1A1CASP1IGLV6-57
SCHEMBL24720187 0.79 S100B (0.64) S100BTDP1ALDH1A1IGLV6-57CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7714009-B2 Nitrogen-containing fused heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-11 US disclosed
US-20070135452-A1 Nitrogen-containing fused heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135452-A1 Nitrogen-containing fused heterocyclic compounds NPY4R, NR4A3, NR3C2 S100B 1979/4885TDP1 4581/4885ALDH1A1 2513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.